|Bid||514.95 x 100|
|Ask||515.52 x 500|
|Day's range||510.00 - 518.57|
|52-week range||325.35 - 543.55|
|PE ratio (TTM)||62.44|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves.
The European Medicines Agency on Friday recommended approval of Regeneron Pharmaceuticals and Sanofi's new drug Dupixent for atopic dermatitis, a product many analysts see as the most important growth driver for the two companies. Recommendations from the agency's expert committee on new drugs are normally endorsed by the European Commission within a couple of months. Atopic dermatitis is a chronic type of skin inflammation also known as eczema, which in severe cases causes constant, often unbearable, itching.
A discussion of the leadership in the biotech group.